2022 Q3 Form 10-Q Financial Statement

#000149315222022434 Filed on August 12, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $67.65K $64.40K $168.5K
YoY Change -55.36% -59.65% -26.9%
Cost Of Revenue $26.35K $41.96K $94.86K
YoY Change -61.33% -13.16% -35.54%
Gross Profit $41.31K $22.44K $73.65K
YoY Change -50.49% -79.84% -11.64%
Gross Profit Margin 61.05% 34.84% 43.71%
Selling, General & Admin $71.76K $32.35K $71.65K
YoY Change -4.42% -68.11% 23.56%
% of Gross Profit 173.74% 144.16% 97.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.330K $8.335K
YoY Change 1442.59% 601.6%
% of Gross Profit 37.12% 11.32%
Operating Expenses $281.5K $240.9K $293.6K
YoY Change 0.85% -24.59% 3.02%
Operating Profit -$240.2K -$218.4K -$219.9K
YoY Change 22.73% 4.95% 9.09%
Interest Expense -$1.500K -$36.09K
YoY Change -96.83% 58.36%
% of Operating Profit
Other Income/Expense, Net -$62.28K -$7.813K $25.54K
YoY Change 279.04% -83.51% -128.75%
Pretax Income -$226.2K -$194.4K
YoY Change -11.46% -33.07%
Income Tax
% Of Pretax Income
Net Earnings -$302.5K -$226.2K -$194.4K
YoY Change 42.58% -11.45% -33.07%
Net Earnings / Revenue -447.08% -351.27% -115.35%
Basic Earnings Per Share -$0.06 $0.00 $0.00
Diluted Earnings Per Share -$0.06 -$920.60 -$825.40
COMMON SHARES
Basic Shares Outstanding 247.1M shares 245.7M shares 235.5M shares
Diluted Shares Outstanding 5.066M shares 3.780M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $62.33K $46.26K
YoY Change -85.59% -88.79%
Cash & Equivalents $24.00K $61.14K $44.89K
Short-Term Investments $1.190K $1.370K
Other Short-Term Assets $17.83K $22.27K $15.66K
YoY Change -87.83% -87.62% -77.67%
Inventory $91.00K $80.52K $84.36K
Prepaid Expenses
Receivables $9.140K $31.67K
Other Receivables $0.00 $0.00
Total Short-Term Assets $157.2K $174.3K $178.0K
YoY Change -73.78% -77.69% -69.67%
LONG-TERM ASSETS
Property, Plant & Equipment $67.46K $75.79K $84.13K
YoY Change 3.34% 7.28% 538.77%
Goodwill
YoY Change
Intangibles $3.308K
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $70.76K $75.79K $84.13K
YoY Change 8.41% 7.28% 538.77%
TOTAL ASSETS
Total Short-Term Assets $157.2K $174.3K $178.0K
Total Long-Term Assets $70.76K $75.79K $84.13K
Total Assets $228.0K $250.1K $262.1K
YoY Change -65.71% -70.64% -56.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $127.2K $122.3K $134.1K
YoY Change -7.05% -26.83% -14.89%
Accrued Expenses $334.1K $345.8K $310.4K
YoY Change 16.44% 27.32% 6.32%
Deferred Revenue $15.98K $19.10K $29.50K
YoY Change -48.43% -39.17% -5.69%
Short-Term Debt $1.780M $1.805M
YoY Change 10.12%
Long-Term Debt Due $37.35K $16.15K
YoY Change 433.57% 37.8%
Total Short-Term Liabilities $3.179M $3.158M $3.131M
YoY Change 5.37% 5.46% 5.03%
LONG-TERM LIABILITIES
Long-Term Debt $144.7K $140.9K
YoY Change -33.61% -35.35%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $144.7K $140.9K
YoY Change -33.61% -35.35%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.179M $3.158M $3.131M
Total Long-Term Liabilities $144.7K $140.9K
Total Liabilities $3.322M $3.302M $3.271M
YoY Change 2.71% 2.81% 2.28%
SHAREHOLDERS EQUITY
Retained Earnings -$26.78M -$26.47M -$26.25M
YoY Change 4.55% 4.23% 5.44%
Common Stock $1.556K $24.71K $23.85K
YoY Change -92.76% 15.09% 28.26%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.094M -$3.052M -$3.009M
YoY Change
Total Liabilities & Shareholders Equity $228.0K $250.1K $262.1K
YoY Change -65.71% -70.64% -56.31%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$302.5K -$226.2K -$194.4K
YoY Change 42.58% -11.45% -33.07%
Depreciation, Depletion And Amortization $8.330K $8.335K
YoY Change 1442.59% 601.6%
Cash From Operating Activities -$128.0K -$141.7K
YoY Change -23.18% 84.67%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 144.2K $48.25K
YoY Change -41.29% -88.32%
NET CHANGE
Cash From Operating Activities -128.0K -$141.7K
Cash From Investing Activities 0.000
Cash From Financing Activities 144.2K $48.25K
Net Change In Cash 16.24K -$93.45K
YoY Change -22.74% -128.22%
FREE CASH FLOW
Cash From Operating Activities -$128.0K -$141.7K
Capital Expenditures
Free Cash Flow -$141.7K
YoY Change 70.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
usd
GTXO Deemed Dividend
DeemedDividend
usd
GTXO Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
usd
CY2021Q4 GTXO Line Of Credit Two
LineOfCreditTwo
usd
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
usd
CY2021Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001375793
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q2 GTXO Paycheck Protection Program Loan Amount
PaycheckProtectionProgramLoanAmount
usd
GTXO Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
GTXO Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
shares
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
usd
dei Entity Registrant Name
EntityRegistrantName
GTX Corp
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
CY2022Q2 GTXO Grant From Care Loans
GrantFromCareLoans
usd
CY2021Q2 GTXO Grant From Care Loans
GrantFromCareLoans
usd
GTXO Grant From Care Loans
GrantFromCareLoans
usd
CY2022Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
usd
CY2022Q2 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
usd
CY2021Q2 us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
usd
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
usd
us-gaap Redeemable Preferred Stock Dividends
RedeemablePreferredStockDividends
usd
CY2022Q2 GTXO Redeemable Preferred Stock Dividends One
RedeemablePreferredStockDividendsOne
usd
GTXO Redeemable Preferred Stock Dividends One
RedeemablePreferredStockDividendsOne
usd
CY2021Q2 GTXO Issuance Of Common Stock Value For Conversion Of Preferred Shares
IssuanceOfCommonStockValueForConversionOfPreferredShares
usd
CY2021Q2 GTXO Adjustments To Additional Paid In Capital Deemed Dividend On Fair Value Of Warrants And Conversion Feature Associated With Preferred Stock
AdjustmentsToAdditionalPaidInCapitalDeemedDividendOnFairValueOfWarrantsAndConversionFeatureAssociatedWithPreferredStock
usd
GTXO Issuance Of Common Stock For Conversion Of Warrants One
IssuanceOfCommonStockForConversionOfWarrantsOne
usd
GTXO Issuance Of Common Stock Value For Conversion Of Preferred Shares
IssuanceOfCommonStockValueForConversionOfPreferredShares
usd
GTXO Adjustments To Additional Paid In Capital Deemed Dividend On Fair Value Of Warrants And Conversion Feature Associated With Preferred Stock
AdjustmentsToAdditionalPaidInCapitalDeemedDividendOnFairValueOfWarrantsAndConversionFeatureAssociatedWithPreferredStock
usd
GTXO Grant From Care Loans
GrantFromCareLoans
usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
usd
GTXO Issuance Of Common Stock For Financings
IssuanceOfCommonStockForFinancings
usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-53046
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0493446
dei Entity Address Address Line1
EntityAddressAddressLine1
117 W. 9th Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1214
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90015
dei City Area Code
CityAreaCode
213
dei Local Phone Number
LocalPhoneNumber
489-3019
dei Security12b Title
Security12bTitle
None
dei Trading Symbol
TradingSymbol
GTXO
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
247107241 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61135 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
138342 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
9143 usd
CY2021Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
13735 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
80517 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
98258 usd
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1190 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
2465 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
22274 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
55016 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
174259 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
307816 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75791 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92461 usd
CY2022Q2 us-gaap Assets
Assets
250050 usd
CY2021Q4 us-gaap Assets
Assets
400277 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
122272 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
182610 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
345814 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
327293 usd
CY2022Q2 GTXO Accrued Expenses Related Parties Current
AccruedExpensesRelatedPartiesCurrent
862928 usd
CY2021Q4 GTXO Accrued Expenses Related Parties Current
AccruedExpensesRelatedPartiesCurrent
839810 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
19100 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
37350 usd
CY2022Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
32000 usd
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
21715 usd
CY2022Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
5347 usd
CY2021Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
74953 usd
CY2022Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
858000 usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
758000 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
889109 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
976545 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
33130 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
40640 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3157700 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3136981 usd
CY2022Q2 us-gaap Long Term Loans Payable
LongTermLoansPayable
144653 usd
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
142917 usd
CY2022Q2 us-gaap Liabilities
Liabilities
3302353 usd
CY2021Q4 us-gaap Liabilities
Liabilities
3279898 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2071000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2071000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
247107241 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
247107241 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
224502479 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
224502479 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
24710 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
22450 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23396878 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23151212 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26473992 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-26053384 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3052303 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2879621 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
250050 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
400277 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
64402 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
159604 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232917 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
390124 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
41962 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
48319 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
136825 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
195643 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
22440 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
111285 usd
us-gaap Gross Profit
GrossProfit
96092 usd
us-gaap Gross Profit
GrossProfit
194643 usd
CY2022Q2 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
131323 usd
CY2021Q2 us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
120159 usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
255088 usd
us-gaap Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
246962 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
77177 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
97789 usd
us-gaap Professional Fees
ProfessionalFees
175339 usd
us-gaap Professional Fees
ProfessionalFees
197961 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5058 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
59803 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
15599 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
69738 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27292 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41648 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
88399 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
89701 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
240850 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
319399 usd
us-gaap Operating Expenses
OperatingExpenses
534425 usd
us-gaap Operating Expenses
OperatingExpenses
604361 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-218410 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-208114 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-438333 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-409719 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-66036 usd
CY2022Q2 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-180 usd
CY2021Q2 us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-1086 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-1275 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
682 usd
CY2022Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
6316 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
12563 usd
GTXO Grant From Care Loans
GrantFromCareLoans
67870 usd
CY2021Q2 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
30705 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
30705 usd
CY2022Q2 GTXO Interest Expense Income And Financing Costs
InterestExpenseIncomeAndFinancingCosts
-1317 usd
CY2021Q2 GTXO Interest Expense Income And Financing Costs
InterestExpenseIncomeAndFinancingCosts
-15579 usd
GTXO Interest Expense Income And Financing Costs
InterestExpenseIncomeAndFinancingCosts
-36307 usd
GTXO Interest Expense Income And Financing Costs
InterestExpenseIncomeAndFinancingCosts
-40138 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7813 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-47370 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17725 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-136197 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-226223 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-255488 usd
us-gaap Net Income Loss
NetIncomeLoss
-420608 usd
us-gaap Net Income Loss
NetIncomeLoss
-545915 usd
CY2021Q2 GTXO Redeemable Preferred Stock Dividends One
RedeemablePreferredStockDividendsOne
250000 usd
GTXO Redeemable Preferred Stock Dividends One
RedeemablePreferredStockDividendsOne
675000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-226223 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-505488 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-420608 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1220915 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
245718753 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
204836548 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
240638838 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
184573105 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-3009406 usd
CY2022Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
33326 usd
CY2022Q2 GTXO Stock Issuance Of Common Stock For Financings
StockIssuanceOfCommonStockForFinancings
150000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-226223 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3052303 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-2598550 usd
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
176400 usd
CY2021Q2 GTXO Adjustment To Additional Paid In Capital Loss On Stock Compensation
AdjustmentToAdditionalPaidInCapitalLossOnStockCompensation
14075 usd
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
22500 usd
CY2021Q2 GTXO Issuance Of Preferred Stock For Financing
IssuanceOfPreferredStockForFinancing
250000 usd
CY2021Q2 GTXO Adjustment To Additional Paid In Capital Imputed Interest Related Parties
AdjustmentToAdditionalPaidInCapitalImputedInterestRelatedParties
30705 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-255488 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2360358 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2879621 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
72926 usd
GTXO Stock Issuance Of Common Stock For Financings
StockIssuanceOfCommonStockForFinancings
150000 usd
GTXO Issuance Of Common Stock For Conversion Of Warrants One
IssuanceOfCommonStockForConversionOfWarrantsOne
25000 usd
us-gaap Net Income Loss
NetIncomeLoss
-420608 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-3052303 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-3104097 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
238150 usd
GTXO Adjustment To Additional Paid In Capital Loss On Stock Compensation
AdjustmentToAdditionalPaidInCapitalLossOnStockCompensation
14075 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
194373 usd
GTXO Issuance Of Preferred Stock For Financing
IssuanceOfPreferredStockForFinancing
675000 usd
GTXO Stock Issuance Of Common Stock For Financings
StockIssuanceOfCommonStockForFinancings
3275 usd
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
131736 usd
GTXO Adjustment To Additional Paid In Capital Imputed Interest Related Parties
AdjustmentToAdditionalPaidInCapitalImputedInterestRelatedParties
30705 usd
GTXO Inpixon Loan Reduction Correction
InpixonLoanReductionCorrection
2340 usd
us-gaap Net Income Loss
NetIncomeLoss
-545915 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2360358 usd
us-gaap Net Income Loss
NetIncomeLoss
-420608 usd
us-gaap Net Income Loss
NetIncomeLoss
-545915 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
16670 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1728 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
-1275 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
682 usd
us-gaap Share Based Compensation
ShareBasedCompensation
72926 usd
us-gaap Share Based Compensation
ShareBasedCompensation
252225 usd
GTXO Grant From Care Loans
GrantFromCareLoans
67870 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
12563 usd
GTXO Issuance Of Common Stock For Financings
IssuanceOfCommonStockForFinancings
3275 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-66036 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
2340 usd
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
30705 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-4592 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15083 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-17740 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1267 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-32743 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
125388 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
2538 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
28307 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
75883 usd
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
90393 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-18150 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5950 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-269697 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-243364 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
64500 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1258 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-63242 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
34180 usd
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
675000 usd
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
25000 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
150000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
7510 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
9180 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
25000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
16293 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
192490 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
658707 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-77207 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
352101 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
138342 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
76912 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
61135 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
429013 usd
us-gaap Interest Paid Net
InterestPaidNet
531 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
194373 usd
GTXO Deemed Dividend
DeemedDividend
675000 usd
GTXO Conversion Of Preferred Stock To Common Stock
ConversionOfPreferredStockToCommonStock
2841 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3052303 usd
CY2022Q2 GTXO Working Capital
WorkingCapital
-2983441 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232917 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
390124 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
232917 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
390124 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
38920 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
38920 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
40351 usd
us-gaap Standard Product Warranty Description
StandardProductWarrantyDescription
The Company’s warranty policy provides repair or replacement of products (excluding GPS Shoe devices) returned for defects within ninety days of purchase
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_843_eus-gaap--UseOfEstimates_zAwNfRxqsV3i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the accompanying unaudited financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates include, but are not limited to, estimates related to revenue recognition, allowance for doubtful accounts, inventory valuation, tangible and intangible long-term asset valuation, warranty and other obligations and commitments. Estimates are updated on an ongoing basis and are evaluated based on historical experience and current circumstances. Changes in facts and circumstances in the future may give rise to changes in these estimates which may cause actual results to differ from current estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zoD4pBzseWa2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We currently rely on one manufacturer to supply us with our GPS SmartSole and one manufacturer to supply us with the GPS device included in the GPS SmartSole. The loss of either of these manufacturers could severely impede our ability to manufacture the GPS SmartSole.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2022, the Company had four customers representing approximately <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zNg4tWqNygse" title="Concentration risk, percentage">38</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zaDqFEFskNEi" title="Concentration risk, percentage">14</span>%, <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zmEwI9MYHxId" title="Concentration risk, percentage">10</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerFourMember_z7iy6KnxYD41" title="Concentration risk, percentage">9</span>% of sales, respectively (of the <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zC6lEmuj45Yk" title="Concentration risk, percentage">38</span>% in receivables represents, this represents sales made through our online store and consists of approximately 2,000 different customers), and four customers representing approximately <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zxrjj4bzKJn2" title="Concentration risk, percentage">23</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zajNkOEwJ4Oi" title="Concentration risk, percentage">7</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zRcVyyMPC5r9" title="Concentration risk, percentage">7</span>% and <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20220101__20220630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zkEFS2G6sO8a" title="Concentration risk, percentage">6</span>% of total accounts receivable, respectively (excluding related party payables).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2021, the Company had three customers representing approximately <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210630__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMAdSiazqPNc">80</span>%, <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_z6BnNwhYQRY1">7</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zA317eDwvB7f">2</span>% of sales, respectively, and three customers representing approximately <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z1TpZMaudPjf">22</span>%, <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zgFYOKdyhSY5">19</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zSIg9j4HREVg">9</span>% of total accounts receivable, respectively (of the <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20210630__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerMember_zg1BXOrFZJT4">80</span>% this represents all sales made through our online store and consists of approximately 2,000+ different customers).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
1190 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
2465 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2020Q4 GTXO Convertible Debt Liability
ConvertibleDebtLiability
0 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
169241667 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
365633334 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
GTXO Investment Owned Description
InvestmentOwnedDescription
The Company’s investments in marketable securities is comprised of shares of stock of two (2) entities with ownership percentages of less than 5%. The Company accounted for these investments pursuant to ASU 320, Investments – Debt and Equity Securities. As such, these investments were recorded at their market value as of December 31, 2019, with the change in fair value being reflected in the statement of operations
CY2020Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
8500 shares
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
38820 usd
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
71936 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
41697 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
25322 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
80517 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
98258 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
438243 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
421573 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
75791 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
92461 usd
us-gaap Depreciation
Depreciation
16670 usd
us-gaap Depreciation
Depreciation
1728 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
33130 usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
40640 usd
CY2022Q2 us-gaap Line Of Credit
LineOfCredit
7000 usd
CY2021Q4 us-gaap Line Of Credit
LineOfCredit
7000 usd
CY2022Q2 GTXO Line Of Credit Two
LineOfCreditTwo
25000 usd
CY2022Q2 us-gaap Other Borrowings
OtherBorrowings
10417 usd
CY2021Q4 us-gaap Other Borrowings
OtherBorrowings
74953 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
75547 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
122593 usd
CY2021Q4 GTXO Paycheck Protection Program Loan Amount
PaycheckProtectionProgramLoanAmount
67870 usd
CY2022Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
858000 usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
758000 usd
CY2022Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
858000 usd
CY2021Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
758000 usd
CY2021Q4 GTXO Paycheck Protection Program Loan Amount
PaycheckProtectionProgramLoanAmount
67870 usd
CY2022Q2 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
10417 usd
CY2021Q4 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
7083 usd
CY2022Q2 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
139583 usd
CY2021Q4 us-gaap Other Loans Payable Long Term
OtherLoansPayableLongTerm
142917 usd
CY2022Q2 GTXO Short Term And Long Term Loans Payable
ShortTermAndLongTermLoansPayable
150000 usd
CY2021Q4 GTXO Short Term And Long Term Loans Payable
ShortTermAndLongTermLoansPayable
217870 usd
CY2022Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
914546 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
0 usd
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
7604762 shares
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
72926 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
49250000 shares
GTXO Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
0.0025
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
10000000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
39250000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022Q2 GTXO Bonus Declared Or Accrued
BonusDeclaredOrAccrued
0 usd
CY2021Q2 GTXO Bonus Declared Or Accrued
BonusDeclaredOrAccrued
0 usd

Files In Submission

Name View Source Status
0001493152-22-022434-index-headers.html Edgar Link pending
0001493152-22-022434-index.html Edgar Link pending
0001493152-22-022434.txt Edgar Link pending
0001493152-22-022434-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
gtxo-20220630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
gtxo-20220630_cal.xml Edgar Link unprocessable
gtxo-20220630_def.xml Edgar Link unprocessable
gtxo-20220630_lab.xml Edgar Link unprocessable
gtxo-20220630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable